Diurnal’s pioneering phase 2 study evaluates modified-release hydrocortisone for adrenal insufficiency
Category: Uncategorized
Updated Date: Wed, 02 Feb 2022 00:00:00 EST
Updated Date: Wed, 02 Feb 2022 00:00:00 EST
Recent declines in the overall rates of covid-19 in the UK have masked the rapid and steep rise […]
BioNTech advocate accused of undermining WHO’s African mRNA production campaign: report fkansteiner Wed, 02/09/2022 – 14:08
A doctor is ending a shift but her patient will be getting some blood draws later. She also […]
MHH study: Vessels of girls suffer more damage than those of boys
As Alderwick points out, the NHS is not providing the level of care expected by UK citizens.1 There […]
Karyopharm ready to take new Xpovio indication to the FDA but analysts hold out for details esagonowsky Wed, […]
